Welcome to our dedicated page for Tenet Healthcare SEC filings (Ticker: THC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Tenet Healthcare Corporation (NYSE: THC) brings together the company’s official regulatory disclosures, offering a structured view of how this diversified healthcare services organization reports its activities in the general medical and surgical hospitals industry. As a Nevada-incorporated public company with common stock and certain senior notes listed on the New York Stock Exchange, Tenet files a range of documents with the U.S. Securities and Exchange Commission.
Key filings include Form 8-K current reports that describe material events such as quarterly earnings releases, new credit agreements, amendments to letter of credit facilities, and issuances of senior secured first lien notes and senior notes. These filings explain how Tenet structures its debt, the terms of its revolving credit facility and borrowing base, and the use of proceeds from note offerings to redeem or partially redeem existing notes. 8-K reports also cover governance matters like director resignations and adjustments to board size.
Investors can also use this page to access periodic reports such as annual and quarterly filings when available, which provide segment information for the Ambulatory business (United Surgical Partners International) and the Hospital Operations and Services segment, as well as details on Conifer Health Solutions’ revenue cycle and value-based care services. These documents help clarify how Tenet’s hospital, ambulatory and services operations are reflected in its financial statements and risk disclosures.
Stock Titan enhances these filings with AI-powered summaries that highlight the most important points from lengthy documents, such as new debt issuances, covenant terms, or changes in financial outlook. Real-time updates from EDGAR, combined with simplified explanations of complex credit agreements and note indentures, allow users to quickly understand how new filings may relate to Tenet’s capital structure, liquidity, and operational focus.
Tenet Healthcare Corporation announced leadership changes in its accounting function. Senior Vice President & Controller and Principal Accounting Officer R. Scott Ramsey will now retire effective April 30, 2026, and continue part-time with the company through March 31, 2028, to provide transition support.
Effective April 6, 2026, Tenet is appointing J. Michael Grooms, age 48, as Senior Vice President & Controller, and he will become Principal Accounting Officer on May 1, 2026. Under his offer letter, Grooms will receive a $475,000 base salary, a target cash bonus equal to 60% of salary, an initial $500,000 RSU grant, eligibility for a 2027 equity award of about $350,000, a $250,000 cash sign-on bonus, and relocation benefits.
The Vanguard Group filed Amendment No. 16 to a Schedule 13G/A reporting 0 shares and 0% beneficial ownership of Tenet Healthcare Corp common stock as part of an internal realignment described under SEC Release No. 34-39538.
The filing states certain Vanguard subsidiaries will report beneficial ownership separately after the realignment dated 01/12/2026, and that The Vanguard Group, Inc. no longer is deemed to beneficially own securities held by those subsidiaries. The form is signed by Ashley Grim on 03/27/2026.
TENET HEALTHCARE CORP executive Paola M. Arbour sold common stock in an open-market transaction. On March 11, 2026, she sold 6,500 shares of Tenet Healthcare common stock at a weighted average price of $238.43 per share, with actual sale prices ranging from $238.40 to $238.68. After this sale, she directly owned 29,291 shares of Tenet Healthcare common stock.
THC filed a Form 144 reporting an intended sale of up to 6,500 shares of Common Stock through Fidelity Brokerage Services LLC. The filing shows an aggregate offering price of $1,549,773.55 and lists the broker as Fidelity Brokerage Services LLC on 03/11/2026.
The notice also lists recent Restricted Stock Vesting events: 984 shares vested on 02/28/2026 and 5,516 shares vested on 03/01/2026, both described as compensation-related. The filing does not state further proceeds treatment or other transaction details.
Tenet Healthcare’s EVP, Chief Administrative Officer and General Counsel, Thomas W. Arnst, reported selling a total of 8,000 shares of common stock in open-market transactions on March 9, 2026. He sold 4,714 shares at a weighted average price of $238.42 and 3,286 shares at a weighted average price of $239.46, in multiple trades within disclosed price ranges. Following these sales, he directly holds 12 shares of Tenet Healthcare common stock.
Tenet Healthcare Corp executive vice president of corporate development Michael T. Maloney filed an initial ownership report showing his equity holdings as of February 27, 2026. The filing lists common stock, performance stock options, and multiple tranches of time-based restricted stock units.
He directly holds common stock and performance stock options from February 2018 and February 2019, along with unvested restricted stock units granted in February 2024, February 2025, and February 2026. The restricted stock units are settled in Tenet common shares upon vesting, with vesting dates running from February 24, 2027 through February 27, 2029. The filing does not show any new purchases or sales, only existing holdings and vesting schedules.
Thomas W. Arnst filed a Form 144 reporting a sale of 24,000 common shares on 03/02/2026. The filing also lists restricted stock vesting entries labeled Compensation: 3,080 shares vested on 02/28/2026 and 4,920 shares vested on 03/01/2026.
Tenet Healthcare CEO Saumya Sutaria reported several equity compensation events involving restricted stock units and common shares. He received a grant of 36,092 2026 February restricted stock units that convert into common stock on a one-for-one basis and vest in one-third increments over three years. Previously granted RSUs from 2023 and 2024 vested, with 22,417 and 36,384 units exercised into common stock on February 27, 2026. To cover withholding taxes tied to performance and restricted stock unit vesting, he disposed of 9,282 common shares at $237.58 and 29,919 and 124,959 shares at $239.39 through tax-withholding transactions, not open-market sales. After these movements, Sutaria directly owned 658,523 shares of Tenet Healthcare common stock.
Tenet Healthcare EVP & CFO Sun Park reported equity compensation and related tax-withholding transactions. On February 27, 2026, Park received a grant of 7,520 time-based restricted stock units, which vest in one-third increments over three years and settle in common shares upon vesting.
On the same date, 4,670 restricted stock units from a 2024 award converted into an equal number of common shares. To cover withholding taxes on vested performance share units and restricted stock units, 1,626 and 1,985 common shares were withheld at prices of $237.58 and $239.39, respectively. After these transactions, Park directly held 19,438 shares of Tenet Healthcare common stock.
Tenet Healthcare EVP and CIO Paola M. Arbour reported equity compensation activity, not open‑market trading. On February 27, 2026, 1,868 restricted stock units from a February 2024 grant and 2,799 units from a March 2023 grant converted into an equal number of common shares. To cover withholding taxes upon vesting of performance and time-based restricted stock units, 499, 1,838 and 6,810 common shares were withheld at closing prices of $237.58 and $239.39 per share. After these conversions and tax-withholding dispositions, Arbour directly held 35,791 shares of Tenet Healthcare common stock.